{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:43:54Z","timestamp":1757706234959},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11914-008-0009-5","type":"journal-article","created":{"date-parts":[[2008,10,12]],"date-time":"2008-10-12T03:35:19Z","timestamp":1223782519000},"page":"51-56","source":"Crossref","is-referenced-by-count":9,"title":["Inhibin and the regulation of bone mass"],"prefix":"10.1007","volume":"6","author":[{"given":"Dana","family":"Gaddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,11]]},"reference":[{"key":"9_CR1","first-page":"298","volume":"55","author":"F. Albright","year":"1940","unstructured":"Albright F, Bloomberg E, Smith PH: Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940, 55:298\u2013305.","journal-title":"Trans Assoc Am Physicians"},{"key":"9_CR2","first-page":"115","volume":"21","author":"S.C. Manolagas","year":"2000","unstructured":"Manolagas SC: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000, 21:115\u2013137.","journal-title":"Endocr Rev"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","volume":"11","author":"T.J. Martin","year":"2005","unstructured":"Martin TJ, Sims NA: Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005, 11:76\u201381.","journal-title":"Trends Mol Med"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/rp.57.1.385","volume":"57","author":"S.C. Manolagas","year":"2002","unstructured":"Manolagas SC, Kousteni S, Jilka RL: Sex steroids and bone. Recent Prog Horm Res 2002, 57:385\u2013409.","journal-title":"Recent Prog Horm Res"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/0470846542.ch15","volume":"242","author":"B.L. Riggs","year":"2002","unstructured":"Riggs BL: Endocrine causes of age-related bone loss and osteoporosis. Novartis Found Symp 2002, 242:247\u2013259; discussion 260\u2013264.","journal-title":"Novartis Found Symp"},{"key":"9_CR6","first-page":"1522","volume":"82","author":"S. Khosla","year":"1997","unstructured":"Khosla S, Atkinson EJ, Melton LJ 3rd, Riggs BL: Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 1997, 82:1522\u20131527.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR7","first-page":"2266","volume":"83","author":"S. Khosla","year":"1998","unstructured":"Khosla S, Melton LJ 3rd, Atkinson EJ, et al.: Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998, 83:2266\u20132274.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"9_CR8","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0025-6196(19)30642-1","volume":"75","author":"B.L. Riggs","year":"2000","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd: Primary osteoporosis in men: role of sex steroid deficiency. Mayo Clin Proc 2000, 75(Suppl):S46\u2013S50.","journal-title":"Mayo Clin Proc"},{"key":"9_CR9","first-page":"3366","volume":"81","author":"P.R. Ebeling","year":"1996","unstructured":"Ebeling PR, Atley LM, Guthrie JR, et al.: Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996, 81:3366\u20133371.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","volume":"19","author":"B.L. Riggs","year":"2004","unstructured":"Riggs BL, Melton Iii LJ 3rd, Robb RA, et al.: Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 2004, 19:1945\u20131954.","journal-title":"J Bone Miner Res"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1359\/jbmr.071020","volume":"23","author":"B.L. Riggs","year":"2008","unstructured":"Riggs BL, Melton LJ, Robb RA, et al.: A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 2008, 23:205\u2013214.","journal-title":"J Bone Miner Res"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L. Sun","year":"2006","unstructured":"Sun L, Peng Y, Sharrow AC, et al.: FSH directly regulates bone mass. Cell 2006, 125:247\u2013260.","journal-title":"Cell"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2004.02.010","volume":"225","author":"L.M. Bilezikjian","year":"2004","unstructured":"Bilezikjian LM, Blount AL, Leal AM, et al.: Autocrine\/paracrine regulation of pituitary function by activin, inhibin and follistatin. Mol Cell Endocrinol 2004, 225:29\u201336.","journal-title":"Mol Cell Endocrinol"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2004-831902","volume":"22","author":"R.W. Cook","year":"2004","unstructured":"Cook RW, Thompson TB, Jardetzky TS, Woodruff TK: Molecular biology of inhibin action. Semin Reprod Med 2004, 22:269\u2013276.","journal-title":"Semin Reprod Med"},{"key":"9_CR15","first-page":"1401","volume":"81","author":"N.P. Groome","year":"1996","unstructured":"Groome NP, Illingworth PJ, O\u2019Brien M, et al.: Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996, 81:1401\u20131405.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR16","first-page":"2742","volume":"81","author":"N.A. Klein","year":"1996","unstructured":"Klein NA, Illingworth PJ, Groome NP, et al.: Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996, 81:2742\u20132745.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR17","first-page":"105","volume":"84","author":"C.K. Welt","year":"1999","unstructured":"Welt CK, McNicholl DJ, Taylor AE, Hall JE: Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999, 84:105\u2013111.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/rp.57.1.257","volume":"57","author":"H.G. Burger","year":"2002","unstructured":"Burger HG, Dudley EC, Robertson DM, Dennerstein L: Hormonal changes in the menopause transition. Recent Prog Horm Res 2002, 57:257\u2013275.","journal-title":"Recent Prog Horm Res"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s001980050066","volume":"8","author":"J.R. Guthrie","year":"1998","unstructured":"Guthrie JR, Ebeling PR, Hopper JL, et al.: A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 1998, 8:282\u2013290.","journal-title":"Osteoporos Int"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/endo.143.1.8580","volume":"143","author":"D. Gaddy-Kurten","year":"2002","unstructured":"Gaddy-Kurten D, Coker JK, Abe E, et al.: Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 2002, 143:74\u201383.","journal-title":"Endocrinology"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1210\/jc.2005-2423","volume":"91","author":"D.S. Perrien","year":"2006","unstructured":"Perrien DS, Achenbach SJ, Bledsoe SE, et al.: Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 2006, 91:1848\u20131854.","journal-title":"J Clin Endocrinol Metab"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.maturitas.2005.01.009","volume":"52","author":"F. Vural","year":"2005","unstructured":"Vural F, Vural B, Yucesoy I, Badur S: Ovarian aging and bone metabolism in menstruating women aged 35\u201350 years. Maturitas 2005, 52:147\u2013153.","journal-title":"Maturitas"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/35006129","volume":"404","author":"K.A. Lewis","year":"2000","unstructured":"Lewis KA, Gray PC, Blount AL, et al.: Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000, 404:411\u2013414.","journal-title":"Nature"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/en.2006-0023","volume":"147","author":"P.G. Farnworth","year":"2006","unstructured":"Farnworth PG, Stanton PG, Wang Y, et al.: Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line. Endocrinology 2006, 147:3462\u20133471.","journal-title":"Endocrinology"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1196\/annals.1315.023","volume":"1038","author":"W. Vale","year":"2004","unstructured":"Vale W, Wiater E, Gray P, et al.: Activins and inhibins and their signaling. Ann N Y Acad Sci 2004, 1038:142\u2013147.","journal-title":"Ann N Y Acad Sci"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1074\/jbc.M704883200","volume":"283","author":"K.C. Kirkbride","year":"2008","unstructured":"Kirkbride KC, Townsend TA, Bruinsma MW, et al.: Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 2008, 283:7628\u20137637.","journal-title":"J Biol Chem"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"14588","DOI":"10.1074\/jbc.M008866200","volume":"276","author":"J. Esparza-Lopez","year":"2001","unstructured":"Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, et al.: Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J Biol Chem 2001, 276:14588\u201314596.","journal-title":"J Biol Chem"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1016\/S0021-9258(19)77820-X","volume":"263","author":"S. Cheifetz","year":"1988","unstructured":"Cheifetz S, Ling N, Guillemin R, Massague J: A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin. J Biol Chem 1988, 263:17225\u201317228.","journal-title":"J Biol Chem"},{"key":"9_CR29","first-page":"1075","volume":"14","author":"T.M. Pierson","year":"2000","unstructured":"Pierson TM, Wang Y, DeMayo FJ, et al.: Regulable expression of inhibin A in wild-type and inhibin alpha null mice. Mol Endocrinol 2000, 14:1075\u20131085.","journal-title":"Mol Endocrinol"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/en.2006-0848","volume":"148","author":"D.S. Perrien","year":"2007","unstructured":"Perrien DS, Akel NS, Edwards PK, et al.: Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 2007, 148:1654\u20131665.","journal-title":"Endocrinology"},{"key":"9_CR31","first-page":"219","volume":"32","author":"D. Gaddy","year":"2007","unstructured":"Gaddy D, Perrien DS, Akel NS, et al.: Anabolic actions of inhibin during distraction osteogenesis. Transactions of the 53rd Annual Meeting of the Orthopaedic Research Society 2007, 32:219.","journal-title":"Transactions of the 53rd Annual Meeting of the Orthopaedic Research Society"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1210\/mend.11.12.0022","volume":"11","author":"S. Harada","year":"1997","unstructured":"Harada S, Sampath TK, Aubin JE, Rodan GA: Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence. Mol Endocrinol 1997, 11:1832\u20131845.","journal-title":"Mol Endocrinol"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.1999.14.2.178","volume":"14","author":"A. Samuels","year":"1999","unstructured":"Samuels A, Perry MJ, Tobias JH: High-dose estrogen induces de novo medullary bone formation in female mice. J Bone Miner Res 1999, 14:178\u2013186.","journal-title":"J Bone Miner Res"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S8756-3282(98)00156-2","volume":"24","author":"J.H. Tobias","year":"1999","unstructured":"Tobias JH, Compston JE: Does estrogen stimulate osteoblast function in postmenopausal women? Bone 1999, 24:121\u2013124.","journal-title":"Bone"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","volume":"147","author":"D. Jia","year":"2006","unstructured":"Jia D, O\u2019Brien CA, Stewart SA, et al.: Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 2006, 147:5592\u20135599.","journal-title":"Endocrinology"},{"key":"9_CR36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1247\/csf.20.319","volume":"20","author":"K. Iba","year":"1995","unstructured":"Iba K, Chiba H, Sawada N, et al.: Glucocorticoids induce mineralization coupled with bone protein expression without influence on growth of a human osteoblastic cell line. Cell Struct Funct 1995, 20:319\u2013330.","journal-title":"Cell Struct Funct"},{"key":"9_CR37","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","volume":"145","author":"C.A. O\u2019Brien","year":"2004","unstructured":"O\u2019Brien CA, Jia D, Plotkin LI, et al.: Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 2004, 145:1835\u20131841.","journal-title":"Endocrinology"},{"key":"9_CR38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"R.S. Weinstein","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC: Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998, 102:274\u2013282.","journal-title":"J Clin Invest"},{"key":"9_CR39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/MCB.11.1.250","volume":"11","author":"M. Centrella","year":"1991","unstructured":"Centrella M, McCarthy TL, Canalis E: Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone. Mol Cell Biol 1991, 11:250\u2013258.","journal-title":"Mol Cell Biol"},{"key":"9_CR40","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","volume":"116","author":"H.J. Kim","year":"2006","unstructured":"Kim HJ, Zhao H, Kitaura H, et al.: Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 2006, 116:2152\u20132160.","journal-title":"J Clin Invest"},{"key":"9_CR41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/ENDO:17:1:29","volume":"17","author":"S. Lotinun","year":"2002","unstructured":"Lotinun S, Sibonga JD, Turner RT: Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression. Endocrine 2002, 17:29\u201336.","journal-title":"Endocrine"},{"key":"9_CR42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coph.2005.07.004","volume":"5","author":"K.E. Poole","year":"2005","unstructured":"Poole KE, Reeve J: Parathyroid hormone\u2014a bone anabolic and catabolic agent. Curr Opin Pharmacol 2005, 5:612\u2013617.","journal-title":"Curr Opin Pharmacol"},{"key":"9_CR43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06057","volume":"187","author":"J.T. Potts","year":"2005","unstructured":"Potts JT: Parathyroid hormone: past and present. J Endocrinol 2005, 187:311\u2013325.","journal-title":"J Endocrinol"},{"key":"9_CR44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jbmr.5650110404","volume":"11","author":"J. Reeve","year":"1996","unstructured":"Reeve J: PTH: a future role in the management of osteoporosis? J Bone Miner Res 1996, 11:440\u2013445.","journal-title":"J Bone Miner Res"},{"key":"9_CR45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0026-0495(76)90124-4","volume":"25","author":"A.M. Parfitt","year":"1976","unstructured":"Parfitt AM: The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metabolism 1976, 25:909\u2013955.","journal-title":"Metabolism"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-008-0009-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-008-0009-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-008-0009-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:16:02Z","timestamp":1709306162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-008-0009-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s11914-008-0009-5","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}